Immediate Impact
65 standout
Citing Papers
Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders
2024 Standout
Comparison of two plasma p-tau217 assays to detect and monitor Alzheimer’s pathology
2024 Standout
Works of Emre Aldinc being referenced
Neurofilament Light Chain as a Biomarker of Hereditary Transthyretin-Mediated Amyloidosis
2020
Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Emre Aldinc | 132 | 36 | 40 | 48 | 48 | 19 | 222 | |
| Marie‐Laure Martin‐Négrier | 178 | 22 | 29 | 81 | 49 | 21 | 298 | |
| G. Said | 111 | 22 | 31 | 150 | 75 | 17 | 299 | |
| Brendan McNeish | 94 | 15 | 15 | 25 | 24 | 23 | 284 | |
| Arum Oh | 99 | 85 | 28 | 42 | 35 | 16 | 222 | |
| Gösta Holmgren | 185 | 50 | 25 | 15 | 24 | 16 | 268 | |
| Caterina Marconi | 84 | 44 | 18 | 20 | 13 | 17 | 232 | |
| Megan Donohue | 82 | 40 | 10 | 29 | 12 | 16 | 262 | |
| Francesca Bertola | 64 | 42 | 14 | 38 | 81 | 20 | 284 | |
| Shinobu Fukumura | 145 | 51 | 42 | 21 | 51 | 28 | 262 | |
| Olivier Quenez | 116 | 71 | 31 | 21 | 83 | 17 | 237 |
All Works
Login with ORCID to disown or claim papers
Loading papers...